Cargando…

Genetics of Anthracycline-Associated Cardiotoxicity

Anthracyclines are a major component of chemotherapies used in many pediatric and adult malignancies. Anthracycline-associated cardiotoxicity (ACT) is a dose-dependent adverse effect that has substantial impact on morbidity and mortality. Therefore, the identification of genetic variants associated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Otaibi, Talal Khalid, Weitzman, Benjamin, Tahir, Usman A., Asnani, Aarti
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068960/ https://www.ncbi.nlm.nih.gov/pubmed/35528837 http://dx.doi.org/10.3389/fcvm.2022.867873

Ejemplares similares

Cardiotoxicity of Anthracyclines
por: Cardinale, Daniela, et al.
Publicado: (2020)

Novel Therapeutics for Anthracycline Induced Cardiotoxicity
por: Vuong, Jacqueline T., et al.
Publicado: (2022)

Risk Factors for Anthracycline-Induced Cardiotoxicity
por: Qiu, Shuo, et al.
Publicado: (2021)

Cardiac MRI assessment of anthracycline-induced cardiotoxicity
por: Mabudian, Leila, et al.
Publicado: (2022)

Mechanisms of Anthracycline-Induced Cardiotoxicity: Is Mitochondrial Dysfunction the Answer?
por: Murabito, Alessandra, et al.
Publicado: (2020)

Relevance of Ferroptosis to Cardiotoxicity Caused by Anthracyclines: Mechanisms to Target Treatments
por: Zhang, Guoxia, et al.
Publicado: (2022)

Molecular mechanisms of anthracycline induced cardiotoxicity: Zebrafish come into play
por: Moossavi, Maryam, et al.
Publicado: (2023)

Novel Cardiac Computed Tomography Methods for the Assessment of Anthracycline Induced Cardiotoxicity
por: Feher, Attila, et al.
Publicado: (2022)

Prevention of Anthracycline-Induced Cardiotoxicity: The Good and Bad of Current and Alternative Therapies
por: Sangweni, Nonhlakanipho F., et al.
Publicado: (2022)

Anthracycline-induced cardiotoxicity: From pathobiology to identification of molecular targets for nuclear imaging
por: Jong, Jeremy, et al.
Publicado: (2022)

Editorial: Novel mechanisms, imaging approaches, and management strategies for anthracycline-induced cardiotoxicity
por: Packard, René R. Sevag, et al.
Publicado: (2023)

Preventive use of beta-blockers for anthracycline-induced cardiotoxicity: A network meta-analysis
por: He, Dongsheng, et al.
Publicado: (2022)

Red Blood Cell Distribution Width Is a Predictive Factor of Anthracycline-Induced Cardiotoxicity
por: Yaegashi, Daiki, et al.
Publicado: (2020)

Exercise Cardio-Oncology: Exercise as a Potential Therapeutic Modality in the Management of Anthracycline-Induced Cardiotoxicity
por: Kang, Dong-Woo, et al.
Publicado: (2022)

High Density Lipoprotein and Its Precursor Protein Apolipoprotein A1 as Potential Therapeutics to Prevent Anthracycline Associated Cardiotoxicity
por: Kluck, George E. G., et al.
Publicado: (2020)

Early Change in Area Strain Detected by 3D Speckle Tracking Is Associated With Subsequent Cardiotoxicity in Patients Treated With Low Doses of Anthracyclines
por: Piveta, Rafael B., et al.
Publicado: (2022)

A global case meta-analysis of three-dimensional speckle tracking for evaluating the cardiotoxicity of anthracycline chemotherapy in breast cancer
por: Zhang, Li, et al.
Publicado: (2022)

Risk factors from Framingham risk score for anthracyclines cardiotoxicity in breast cancer: A systematic review and meta-analysis
por: Jin, Hao, et al.
Publicado: (2023)

Comparative efficacy and pharmacological mechanism of Chinese patent medicines against anthracycline-induced cardiotoxicity: An integrated study of network meta-analysis and network pharmacology approach
por: Rao, Yifei, et al.
Publicado: (2023)

Statins to mitigate cardiotoxicity in cancer patients treated with anthracyclines and/or trastuzumab: a systematic review and meta-analysis
por: Obasi, Mary, et al.
Publicado: (2021)

Anthracycline Chemotherapy and Cardiotoxicity
por: McGowan, John V, et al.
Publicado: (2017)

Pregnancy and Cardiomyopathy After Anthracyclines in Childhood
por: Thompson, Kara Annette
Publicado: (2018)

Genetic Susceptibility and Mechanisms Underlying the Pathogenesis of Anthracycline-Associated Cardiotoxicity
por: Ding, Yonghe, et al.
Publicado: (2022)

Cardiotoxicity of Anticancer Therapeutics
por: Dong, Jerry, et al.
Publicado: (2018)

Anthracycline-induced cardiotoxicity and senescence
por: Booth, Laura K., et al.
Publicado: (2022)

The role of iron in anthracycline cardiotoxicity
por: Gammella, Elena, et al.
Publicado: (2014)

Updates in Anthracycline-Mediated Cardiotoxicity
por: Nebigil, Canan G., et al.
Publicado: (2018)

Metabolic Aspects of Anthracycline Cardiotoxicity
por: Russo, Michele, et al.
Publicado: (2021)

Epigenetic Changes Associated With Anthracycline‐Induced Cardiotoxicity
por: Tantawy, Marwa, et al.
Publicado: (2020)

The puzzling clinical presentation of fluoropyrimidines cardiotoxicity
por: Cucciniello, Linda, et al.
Publicado: (2022)

The broad spectrum of cardiotoxicities from immunotherapies
por: Iengo, Martina, et al.
Publicado: (2023)

Differential expression of epigenetic modifiers in early and late cardiotoxic heart failure reveals DNA methylation as a key regulator of cardiotoxicity
por: Robinson, Emma L., et al.
Publicado: (2023)

Pattern of cardiac surveillance among patients with lymphoma receiving anthracycline-based chemotherapy
por: Hung, Olivia Y, et al.
Publicado: (2015)

Coronary microcirculation damage in anthracycline cardiotoxicity
por: Galán-Arriola, Carlos, et al.
Publicado: (2021)

Cardiovascular Magnetic Resonance in Early Detection of Radiation Associated Cardiotoxicity With Chest Radiation
por: Vallabhaneni, Srilakshmi, et al.
Publicado: (2022)

Role and molecular mechanism of traditional Chinese medicine in preventing cardiotoxicity associated with chemoradiotherapy
por: Lv, Xin-Fang, et al.
Publicado: (2022)

Anthracycline Cardiotoxicity: Prevalence, Pathogenesis and Treatment
por: Volkova, Maria, et al.
Publicado: (2011)

Cardiotoxicity of anthracycline therapy: current perspectives
por: Valcovici, Mihaela, et al.
Publicado: (2016)

Demystifying the Relationship Between Metformin, AMPK, and Doxorubicin Cardiotoxicity
por: Singh, Manrose, et al.
Publicado: (2022)

Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection
por: Morelli, Marco Bruno, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lvo8b98jq434dcm5fc8bc66ks2